Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1.
Endotoxin-related acute kidney injury has been shown to profoundly induce nitric oxide (NO), which activates sympathetic and renin-angiotensin system, resulting in renal vasoconstriction. While vascular muscle cells are known to upregulate inducible NO synthase (iNOS), less is known about the endothelium as a source of NO during endotoxemia. Studies were, therefore, undertaken both in vitro in mouse microvascular endothelial cells and in vivo in transgenic mice with overexpression of endothelial GTP cyclohydrolase, the rate-limiting enzyme for tetrahydrobiopterin, a cofactor for NO synthase. LPS significantly induced endothelial cell iNOS expression and NO concentration in the culture media, with no change in endothelial NO synthase expression. GTP cyclohydrolase-1 transgenic (Tg) mice demonstrated a significant increase in baseline urine NO-to-creatinine ratio and a more significant increase in renal iNOS expression and serum NO levels with LPS treatment compared with the wild-type (WT) mice. Glomerular filtration rate and renal blood flow decreased significantly in Tg mice with 1.0 mg/kg LPS, while no changes were observed in WT with the same dose of LPS. Serum IL-6 levels were significantly higher in Tg compared with WT mice during endotoxemia. The antioxidant tempol improved the glomerular filtration rate in the Tg mice. Thus endothelium can be an important source of iNOS and serum NO concentration during endotoxemia, thereby increasing the sensitivity to AKI. Reactive oxygen species appear to be involved in this acute renal injury in Tg mice during endotoxemia.
Wang
Wei
W
Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262-0001, USA.
Zolty
Einath
E
Falk
Sandor
S
Summer
Sandra
S
Zhou
Zhu
Z
Gengaro
Patricia
P
Faubel
Sarah
S
Alp
Nicholas
N
Channon
Keith
K
Schrier
Robert
R
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000201:enzymology* / Q000378:metabolism; D000578:Amidines / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001596:Benzylamines / Q000494:pharmacology; D001708:Biopterins / Q000031:analogs & derivatives / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003497:Cyclic N-Oxides / Q000494:pharmacology; D016207:Cytokines / Q000097:blood; D042783:Endothelial Cells / Q000378:metabolism; D004731:Endotoxins / Q000633:toxicity*; D006136:GTP Cyclohydrolase / Q000235:genetics / Q000378:metabolism; D005919:Glomerular Filtration Rate / Q000187:drug effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009569:Nitric Oxide / Q000097:blood / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012079:Renal Circulation / Q000187:drug effects; D013113:Spin Labels; D019459:Urothelium / Q000378:metabolism*
D000578:Amidines; D000975:Antioxidants; D001596:Benzylamines; D003497:Cyclic N-Oxides; D016207:Cytokines; D004731:Endotoxins; C104820:N-(3-(aminomethyl)benzyl)acetamidine; D013113:Spin Labels; D001708:Biopterins; D009569:Nitric Oxide; D052247:Nitric Oxide Synthase Type II; D006136:GTP Cyclohydrolase; C003402:sapropterin; C001803:tempol